3176
D. Shingnapurkar et al. / Bioorg. Med. Chem. Lett. 22 (2012) 3172–3176
2. World Health Organization report 2011, Global Tuberculosis Control. The
100
90
80
70
60
50
40
30
20
10
0
92
89
burden of disease caused by TB, WHO Press: Geneva, Switzerland, 2011.
3. Stewart, G.; Robertson, B.; Young, D. Nat. Rev. Microbiol. 2003, 1, 97.
4. Augustynowicz-Kopec, E.; Zwolska, Z. Acta Poloniae Pharmaceutica. 2002, 59,
452.
5. Augustynowicz-Kopec, E.; Zwolska, Z. Acta Poloniae Pharmaceutica. 2002, 59,
443.
6. Payton, M.; Auty, R.; Delgoda, R.; Everett, M.; Sim, E. J. Bacteriol. 1999, 181,
1343.
7. Hearn, M.; Cynamon, M. H. J. Antimicrob. Chemother. 2004, 53, 185.
8. Hearn, M.; Cynamon, M.; Chen, M.; Coppins, R.; Davis, J.; Joo-On Kang, H.;
Noble, A.; Tu-Sekine, B.; Terrot, M.; Trombino, D.; Thai, M.; Webster, E.; Wilson,
R. Eur. J. Med. Chem. 2009, 44, 4169.
9. (a) Höner, Zu; Bentrup, K.; Russell, D. Trends Microbiol. 2001, 9, 597; (b)
Fenhalls, G.; Wong, A.; Bezuidenhout, J.; Helden, P.; Bardin, P.; Lukey, P. Infect.
Immun. 2000, 68, 2827.
10. Vanni, P.; Giachetti, E.; Pinzauti, G.; McFadden, B. Comp. Biochem. Physiol. 1990,
95B, 431.
11. McKinney, J. D.; Höner zu Bentrup, K.; Muñoz-Elías, E. J.; Miczak, A.; Chen, B.;
Chan, W. T.; Swenson, D.; Sacchettini, J. C.; Jacobs, W. R., Jr.; Russell, D. G.
Nature 2000, 406, 735.
61.7
56.5
51
41.9
L2
18.4
L3
6.1
L1
M1
M2
M3
L4
M4
Compounds
Figure 5. Antibacterial activity against H37Rv of PA (L1–L4) and MPA (M1–M4).
12. Terwilliger, T. C.; Park, M. S.; Waldo, G. S.; Berendzen, J.; Hung, L. W., et al
Tuberculosis 2003, 83, 223.
13. Sharma, V.; Sharma, S.; Hoener zu Bentrup, K.; McKinney, J. D.; Russell, D. G.;
Jacobs, W. R., Jr.; Sacchettini, J. C. Nat. Struct. Biol. 2000, 7, 663.
14. Sriram, D.; Yogeeswari, P.; Methuku, S.; Vyas, D.; Senthilkumar, P.; Alvala, M.;
Jeankumar, V. Bioorg. Med. Chem. Lett. 2011, 21, 5149.
15. Sriram, D.; Yogeeswari, P.; Vyas, D.; Senthilkumar, P.; Bhat, P.; Srividya, M.
Bioorg. Med. Chem. Lett. 2010, 20, 4313.
16. Sriram, D.; Yogeeswari, P.; Senthilkumar, P.; Naidu, G.; Bhat, P. J. Enzyme Inhib.
Med. Chem. 2010, 25, 765.
17. Sriram, D.; Yogeeswari, P.; Senthilkumar, P.; Sangaraju, D.; Nelli, R.; Banerjee,
D.; Bhat, P.; Manjashetty, T. Chem. Biol. Drug Des. 2010, 75, 381.
18. Sriram, D.; Yogeeswari, P.; Senthilkumar, P.; Dewakar, S.; Rohit, N.; Debjani, B.;
Bhat, P.; Veugopal, B.; Pavan, V.; Thimmappa, H. Med. Chem. 2009, 5, 422.
19. Banerjee, D.; Yogeeswari, P.; Bhat, P.; Thomas, A.; Srividya, M.; Sriram, D. Eur. J.
Med. Chem. 2011, 46, 106.
20. (a) Britton, K.; Abeysinghe, S.; Baker, P.; Barynin, V.; Diehl, P.; Langridge, S.;
McFadden, B.; Sedelnikova, S.; Stillman, T.; Weeradechapona, K.; Rice, D. Acta
Cryst. 2001, D57, 1209; (b) LaPorte, D.; Thorsness, P.; Koshland, D., Jr. J. Biol.
Chem. 1985, 260, 10563.
of literature reports stating that Mtb is much more susceptible to
copper than other bacteria and is killed in vitro by copper concen-
trations lower than those found in phagosomes of macrophages. It
has also been suggested that the mammalian host uses copper to
control Mtb infection and copper resistance mechanisms are cru-
cial for Mtb virulence.39 Ito and group have shown that INH pro-
duced DNA damages in the presence of Cu(II) ions due to active
oxygen species other than the hydroxyl free radical, presumably
by the Cu-(1)–peroxide complex.40 In many cases metal coordina-
tion has been used to confer antibacterial and antiproliferative
properties to different INH derivatives due to enhanced lipophilic-
ity conferred by metal complexation.41,42 It has also been reported
that presence of Cu2+ improves the uptake of INH and analogous
hydrazides into both susceptible and resistant mycobacteria.43
In summary, we have been able to synthesize pyruvate–
isoniazid conjugates and their copper complexes with potent
anti-tubercular activities against M. tuberculosis H37Rv. The
compounds obviously need to be investigated further for their
mechanistic details of their ICL inhibitory activities.
21. (a) Yin, H. D.; Chen, S. W.; Li, L. W.; Wang, D. Inorganica Chim. Acta 2007, 360,
2215; Turta, C. I.; Chapurina, L. F.; Donica, I. G.; Voronkova, V.; Healey, E. R.;
Kravtsov, V. C. Inorganica Chim. Acta 2008, 361, 309.
22. Kumar, R.; Bhakuni, V. Proteins 2008, 72, 892.
23. Newman, M. S.; Lord, B. T. J. Am. Chem. Soc. 1944, 66, 731.
24. Zhengyin, Y.; Rudong, Y.; Kaibei, Y. Polyhedron 1996, 15, 3771.
25. Ertem, G.; West, D. Trans. Metal Chem. 1985, 10, 131.
26. Yu, S.; Wang, S.; Luo, Q.; Wang, L.; Peng, Z.; Gao, X. Polyhedron 1993, 12, 1093.
27. Wallis, S. C.; Gahan, L. R.; Charles, B. G.; Hambley, T. W.; Duckworth, P. A. J.
Inorg. Biochem. 1996, 62, 1.
Acknowledgments
D.V.S. acknowledges Torrents Pharmaceuticals (Ahmedabad,
India) for the fellowship. P.D. acknowledges Human Resource
Development Group, Council of Scientific & Industrial Research,
New Delhi, INDIA for providing Senior Research Fellowship.
ˇ
28. Turel, I.; Golic, L.; Leonel, O.; Ramirez, R. Polyhedron 2000, 19, 441.
29. Franco, E.; López-Torres, E.; Mendiola, M.; Sevilla, M. Polyhedron 2000, 19, 441.
30. Sonawane, P.; Kumbhar, A.; Padhye, S.; Butcher, R. Trans. Metal Chem. 1994, 19,
277.
31. Bindu, P.; Kurup, P.; Satyakeerty, T. Polyhedron 1998, 18, 321.
32. Yang, Z.; Yang, R.; Yu, K. Polyhedron 1996, 15, 3749.
33. Koh, L.; Kon, O.; Loh, K. W.; Long, Y.; Ranford, J.; Tan, A.; Tjan, Y. J. Inorg.
Biochem. 1998, 72, 155.
Supplementary data
34. Endres, H.; Nothe, D.; Rossato, E.; Hatfield, W. Inorg. Chem. 1984, 23, 3467.
35. Drevensek, P.; Zupancic, T.; Pihlar, B.; Jerala, R.; Kolitsch, U.; Plaper, A.; Turel, I.
J. Inorg. Biochem. 2005, 99, 432.
36. Wolschendorf, F.; Ackart, D.; Shrestha, T.; Hascall-Dove, L.; Nolan, S.;
Lamichhane, G.; Wang, Y.; Bossmann, S.; Basaraba, R.; Niederweis, M. Proc.
Natl. Acad. Sci. U.S.A. 2011, 108, 1621.
Experimental details of synthetic procedures and characteriza-
tion data of L1–L4 and M1–M4, crystal data tables of L1, L2 and M1
(Table 2) were given. CCDC 632417, 679623, 633548 contains the
supplementary crystallographic data for L1, L2, and M1, respec-
tively. These data can be obtained free of charge via http://
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ,
UK; fax: (+44) 1223 336 033; or e-mail: deposit@ccdc.cam.ac.uk.
Supplementary data associated with this article can be found, in
37. Kumar, R.; Bhakuni, V. Proteins 2008, 72, 892.
38. Yang, Z.; Yand, R. Polyhedron 1996, 15, 3771.
39. Ito, K.; Yamamoto, K.; Kawanishi, S. Biochemistry 1992, 31, 11606.
40. Voyatzakis, V.; Vasilikiotis, G.; Karageorgiou, G.; Kassapoglou, I. J. Pharm. Sci.
1968, 57, 1255.
41. Maccari, R.; Ottanà, R.; Bottari, B.; Rotondo, E.; Vigorita, M. Bioorg. Med. Chem.
Lett. 2004, 14, 5731.
42. Patole, J.; Sandbhor, U.; Padhye, S.; Deobagkar, D.; Anson, C.; Powell, A. Bioorg.
Med. Chem. Lett. 2003, 13, 51.
43. Bottari, B.; Maccari, R.; Monforte, F.; Ottanà, R.; Vigorita, M.; Bruno, G.; Nicolò,
F.; Rotondo, A.; Rotondo, E. Bioorg. Med. Chem. 2001, 9, 2203.
References and notes
1. Pepper, D. J.; Meintjes, G. A.; McIlleron, H.; Wilkinson, R. J. Drug Discovery Today
2007, 12, 980.